PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1708265
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1708265
Global Home Infusion Therapy Market is estimated to be valued at US$ 26.18 Bn in 2025 and is expected to reach US$ 41.49 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | US$ 26.18 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | US$ 41.49 Bn |
Home infusion therapy refers to the delivery of medications and nutrients directly into a patient's bloodstream at home, through an intravenous (IV) device or IV catheter. It allows patients to receive various therapies in the comfort of their own home, instead of visiting a healthcare facility. A number of chronic diseases and conditions, such as cancer, congestive heart failure, immunotherapy, and diabetes, are increasingly being treated through home infusion therapy. Growing geriatric population, increasing prevalence of chronic diseases, cost competitiveness compared to hospitalization, and technological advancements in home infusion devices are the major factors driving this market. However, lack of skilled healthcare professionals, stringent regulations, and reimbursement issues may restrain the market to a certain extent.
The global home infusion therapy market is driven by factors such as growing geriatric population, increasing prevalence of chronic diseases, cost competitiveness as compared to hospitalization, and technological advancements in home infusion devices. As per WHO, the global geriatric population is expected to reach approximately 1.5 billion by 2050, up from 900 million in 2015. Moreover, rising cases of chronic conditions such as cancer, diabetes, congestive heart failure, and autoimmune diseases are increasing the demand for home infusion therapy. Home infusion therapy allows patients to receive treatment in comfort of their home, avoiding high costs associated with hospital stays. However, lack of skilled healthcare professionals especially in developing regions, stringent regulations, and issues regarding reimbursement policies pose a challenge to market growth. Lack of awareness in some countries also restrains the market growth. Nevertheless, ongoing research and introduction of new home infusion therapy devices are expected to create growth opportunities for market players.
Detailed Segmentation-